A Clinical study to compare the effect of Palasa kshara bhavita Pippali and Rohithakadi choornam along with Phalatrikadi kwatha in patients of Gall Bladder stone.

A CLINICAL STUDY TO EVALUATE THE EFFECT OF PALASA KSHARA BHAVITA PIPPALI IN COMPARISON TO ROHITHAKADI CHOORNAM ALONG WITH PHALATRIKADI KWATHA IN CHRONIC CHOLELITHIASIS

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/11/029028

Enrollment

Registered

2020-11-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K808- Other cholelithiasis

Interventions

Intervention1: Palasa Kshara bhavita Pippali: Palasa Kshara bhavita pippali choornam Capsule 500 mg BD for 30 days Control Intervention1: Rohithakadi Choornam with Phalatrikadi kwatha: Rohithakadi Cho

Eligibility

Inclusion criteria

Inclusion criteria: Patients with chronic cholelithiasis and chronic calculous cholecystitis Solitary or multiple stone & large stone measuring not > 1 cm

Exclusion criteria

Exclusion criteria: Age below 18 years and above 70 years Acute cholelithiasis Pregnant women GB CA Choledocolithiasis Large stone measuring >1 cm Known case of Tubercular Patients Malignancy HIV patients Hepatitis B patients Â

Design outcomes

Primary

Measure	Time frame
Size of Stone by USG GB Wall thickness by USGTimepoint: on 0th day and 31st day	—

Secondary

Measure	Time frame
FLATULENT DYSPEPSIA - DSAS score Timepoint: On 0th, 15th and 31st day;Pain Wong Baker scaleTimepoint: On 0th , 15th and 31st day;PRAKRTHI-TNMC 2004 QuetionnaireTimepoint: On 0th day;Tenderness-RUQTimepoint: On 0th, 15th and 31st day	—

Countries

India

Contacts

Public ContactDr Lakshman Singh

Banaras Hindu University

drlsingh@bhu.ac.in9415687065

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026